Krilogy Financial LLC Amgen Inc Transaction History

Krilogy Financial LLC

$1.35 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $13,095 - $15,961	-58 Reduced 1.31%	4,365 $1.06 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $112,682 - $143,176	-492 Reduced 10.01%	4,423 $1.16 Million
Q3 2022 Oct 06, 2022	SELL	$224.46 - $253.15 $17,956 - $20,252	-80 Reduced 1.6%	4,915 $1.11 Million
Q2 2022 Jul 14, 2022	SELL	$230.71 - $256.74 $200,256 - $222,850	-868 Reduced 14.8%	4,995 $1.22 Million
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $587,424 - $649,845	2,679 Added 84.14%	5,863 $1.42 Million
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $75,375 - $86,260	-379 Reduced 10.64%	3,184 $716,000
Q3 2021 Oct 25, 2021	BUY	$212.27 - $248.7 $88,304 - $103,459	416 Added 13.22%	3,563 $758,000
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $50,453 - $55,974	-216 Reduced 6.42%	3,147 $767,000
Q1 2021 Apr 21, 2021	SELL	$221.91 - $258.6 $73,230 - $85,338	-330 Reduced 8.94%	3,363 $837,000
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $3,245 - $3,865	15 Added 0.41%	3,693 $849,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $246,851 - $274,519	1,052 Added 40.06%	3,678 $935,000
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $112,158 - $137,633	567 Added 27.54%	2,626 $619,000
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $14,214 - $18,852	-78 Reduced 3.65%	2,059 $417,000
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $6,054 - $7,782	32 Added 1.52%	2,137 $515,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $189,779 - $227,395	-1,090 Reduced 34.12%	2,105 $407,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $106,354 - $124,671	638 Added 24.95%	3,195 $589,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $1,266 - $1,427	7 Added 0.27%	2,557 $486,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $54,412 - $63,516	305 Added 13.59%	2,550 $496,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $741 - $835	4 Added 0.18%	2,245 $465,000
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $830 - $932	5 Added 0.22%	2,241 $414,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $40,832 - $47,718	241 Added 12.08%	2,236 $381,000
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $37,302 - $41,678	-221 Reduced 9.97%	1,995 $347,000
Q3 2017 Nov 15, 2017	SELL	$167.29 - $191.0 $152,066 - $173,619	-909 Reduced 29.09%	2,216 $413,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,125	3,125 $538,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.

Account